It has also been widely indicated that IDO1, the first rate-limiting enzyme in the tryptophan-kynurenine (Trp-kyn) metabolism pathway, is upregulated in various cancer tissues, including ovarian cancer, and is related to poor patient prognosis [64–67]. Here, IDO1 is linked to cancer.